These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
28. [Prevention of tuberculosis]. Dautzenberg B. Rev Pneumol Clin; 1994 Sep; 50(5):275-9. PubMed ID: 7899762 [Abstract] [Full Text] [Related]
29. Isoniazid chemoprophylaxis for dual HIV-TB infection: a cautionary tale. FitzGerald JM. Can Commun Dis Rep; 1995 Feb 28; 21(4):29-32; discussion 32, 35. PubMed ID: 7735192 [No Abstract] [Full Text] [Related]
30. [Effectiveness of isoniazid in tuberculosis chemoprophylaxis in children with rising tuberculin sensitivity]. Mitinskaia LA, Elufimova VF, Iukhimenko NV, Demeshko ND, Zriachkina LI, Pesnia NP. Probl Tuberk; 1995 Feb 28; (2):5-6. PubMed ID: 7777467 [Abstract] [Full Text] [Related]
31. A refined symptom-based approach to diagnose pulmonary tuberculosis in children. Marais BJ, Gie RP, Hesseling AC, Schaaf HS, Lombard C, Enarson DA, Beyers N. Pediatrics; 2006 Nov 28; 118(5):e1350-9. PubMed ID: 17079536 [Abstract] [Full Text] [Related]
32. [Tuberculosis outbreak in a junior high school in Kochi City--studies on factors relating to extent of tuberculosis infection and the efficacy of isoniazid chemoprophylaxis]. Toyota M, Morioka S. Kekkaku; 2001 Sep 28; 76(9):625-34. PubMed ID: 11676120 [Abstract] [Full Text] [Related]
33. Effectiveness of isoniazid chemoprophylaxis for HIV-infected drug users at high risk for active tuberculosis. Gourevitch MN, Hartel D, Selwyn PA, Schoenbaum EE, Klein RS. AIDS; 1999 Oct 22; 13(15):2069-74. PubMed ID: 10546859 [Abstract] [Full Text] [Related]
34. Tuberculosis chemotherapy and sputum conversion among HIV-seropositive and HIV-seronegative patients in south-eastern Uganda. Bwire R, Borgdorff MW, Sticht-Groh V, Rieder HL, Kawuma HJ, Bretzel G, Rüsch-Gerdes S. East Afr Med J; 1999 Jun 22; 76(6):307-13. PubMed ID: 10750516 [Abstract] [Full Text] [Related]
35. Isoniazid TB prophylaxis effective in drug users with HIV. J Int Assoc Physicians AIDS Care; 1996 Jun 22; 2(6):51. PubMed ID: 11363698 [Abstract] [Full Text] [Related]
36. [Factors for the onset of and the exacerbation of tuberculosis. 3. Clinical factors for the development and the exacerbation of active tuberculosis. a. Children, young adult]. Takamatsu I. Kekkaku; 1999 Oct 22; 74(10):741-6. PubMed ID: 10565135 [Abstract] [Full Text] [Related]
37. Isoniazid preventive therapy in human immunodeficiency virus-infected persons. Long-term effect on development of tuberculosis and survival. Moreno S, Miralles P, Diaz MD, Baraia J, Padilla B, Berenguer J, Alberdi JC. Arch Intern Med; 1999 Oct 22; 157(15):1729-34. PubMed ID: 9250234 [Abstract] [Full Text] [Related]
38. Controlled chemoprophylaxis trials in tuberculosis. A general review. Ferebee SH. Bibl Tuberc; 1970 Oct 22; 26():28-106. PubMed ID: 4903501 [No Abstract] [Full Text] [Related]
39. Widespread HIV counseling and testing linked to a community-based tuberculosis control program in a high-risk population. Desormeaux J, Johnson MP, Coberly JS, Losikoff P, Johnson E, Huebner R, Geiter L, Davis H, Atkinson J, Chaisson RE, Boulos R, Halsey NA. Bull Pan Am Health Organ; 1996 Mar 22; 30(1):1-8. PubMed ID: 8919719 [Abstract] [Full Text] [Related]